Amgen 1Q Revenues: $5.6 billion(+2%) 1Q Earnings: $2.3 billion (+12%) Comments: New and recently launched products performed well in the quarter. Repatha sales were up 151% to $123 million driven primarily by higher unit demand. KYPROLIS sales increased 17% to $222 million. Prolia sales increased 16% to $494 million. XGEVA sales increased 11% to $445 million. Sensipar/Mimpara sales increased 18% to $497 million. BLINCYTO sales increased 44% to $49 million. NEUPOGEN sales continued to decline,...